Can we objectively measure the human cost of disease?

Por Palazzo, Fabio, Stirparo, Giuseppe, Terranova, Lorenzo
Publicado em 2003

Discrepancies between European countries and USA and Canada in the availability of triptans and in their licensed clinical properties

Por Stirparo, Giuseppe, Palazzo, Fabio, De Filippis, Sergio, Martelletti, Paolo
Publicado em 2003

A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache

Por Mennini, Francesco S., Fioravanti, Laura, Piasini, Laura, Palazzo, Fabio, Coloprisco, Gabriella, Martelletti, Paolo
Publicado em 2004

Price differentials of oral triptans in eight European Union countries

Por Folino-Gallo, Pietro, Palazzo, Fabio, Stirparo, Giuseppe, De Filippis, Sergio, Martelletti, Paolo
Publicado em 2003

A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache

Por Palazzo, Fabio, Mennini, Francesco G., Fioravanti, Laura, Piasini, Laura, Coloprisco, Gabriella, Martelletti, Paolo
Publicado em 2004

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

Por Rossi, Paolo Giorgi, Ricciardi, Alessandro, Cohet, Catherine, Palazzo, Fabio, Furnari, Giacomo, Valle, Sabrina, Largeron, Nathalie, Federici, Antonio
Publicado em 2009